Children's Hospital and Medical Center

Fingerprint The fingerprint is based on mining the text of the scientific documents related to the associated persons. Based on that an index of weighted terms is created, which defines the key subjects of research unit

Pediatrics Medicine & Life Sciences
Heart Diseases Medicine & Life Sciences
Echocardiography Medicine & Life Sciences
Sjogren-Larsson Syndrome Medicine & Life Sciences
Newborn Infant Medicine & Life Sciences
Magnetic Resonance Spectroscopy Medicine & Life Sciences
Therapeutics Medicine & Life Sciences
Hypoplastic Left Heart Syndrome Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Profiles

No photo of Minnie Abromowitch

Minnie Abromowitch, MD

Person: Member, Academic, Clinician

19832017
No photo of Jill C Beck

Jill C Beck, MD

Person: Member, Academic, Clinician

20102017
No photo of David Lloyd Bolam

David Lloyd Bolam, MD

Person: Academic, Clinician

19732010

Research Output 1973 2018

A 6-month, multicenter, open-label study of fixed dose naproxen/esomeprazole in adolescent patients with juvenile idiopathic arthritis

Lovell, D. J., Dare, J. A., Francis-Sedlak, M., Ball, J., LaMoreaux, B. D., Von Scheven, E., Reinhardt, A., Jerath, R., Alpan, O., Gupta, R., Goldsmith, D., Zeft, A., Naddaf, H., Gottlieb, B., Jung, L. & Holt, R. J., Jun 26 2018, In : Pediatric Rheumatology. 16, 1, 41.

Research output: Contribution to journalArticle

Esomeprazole
Naproxen
Juvenile Arthritis
Stomach Ulcer
Pediatrics

Age and Mortality in Pediatric Severe Traumatic Brain Injury: Results from an International Study

For The Investigators Of The Adapt Trial, Feb 23 2018, (Accepted/In press) In : Neurocritical Care. p. 1-12 12 p.

Research output: Contribution to journalArticle

Craniocerebral Trauma
Pediatrics
Glasgow Coma Scale
Mortality
Child Mortality

An immune tolerance approach using transient low-dose methotrexate in the ERT-naïve setting of patients treated with a therapeutic protein: experience in infantile-onset Pompe disease

Kazi, Z. B., Desai, A. K., Troxler, R. B., Kronn, D., Packman, S., Sabbadini, M., Rizzo, W. B., Scherer, K., Abdul-Rahman, O., Tanpaiboon, P., Nampoothiri, S., Gupta, N., Feigenbaum, A., Niyazov, D. M., Sherry, L., Segel, R., McVie-Wylie, A., Sung, C., Joseph, A. M., Richards, S. & 1 othersKishnani, P. S., Jan 1 2018, (Accepted/In press) In : Genetics in Medicine.

Research output: Contribution to journalArticle

Glycogen Storage Disease Type II
Immune Tolerance
Methotrexate
Proteins
Therapeutics